1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
  4. > France Infectious Diagnostics Market Outlook to 2021

France Infectious Diagnostics Market Outlook to 2021

  • September 2015
  • -
  • Global Data
  • -
  • 64 pages

France Infectious Diagnostics Market Outlook to 2021

Summary

GlobalData’s new report, "France Infectious Diagnostics Market Outlook to 2021", provides key market data on the France Infectious Diagnostics market. The report provides value, in millions of US dollars within market segments - Hepatitis Viruses, Retroviruses, Infectious Diagnostics Multiple Parameters Panels, Bacteriology, Nucleic Acid Testing Instruments, Other Virology, Infectious Diagnostics Rapid Tests & POC and Parasitology & Mycology.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Infectious Diagnostics market includes Hepatitis Viruses, Retroviruses, Infectious Diagnostics Multiple Parameters Panels, Bacteriology, Nucleic Acid Testing Instruments, Other Virology, Infectious Diagnostics Rapid Tests & POC and Parasitology & Mycology.
- Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Infectious Diagnostics market.
- Global corporate-level profiles of key companies operating within the France Infectious Diagnostics market.
- Key players covered include Siemens Healthcare, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Hologic, Inc., Qiagen N.V., Becton, Dickinson and Company, Danaher Corporation and Alere Inc..

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table Of Contents

France Infectious Diagnostics Market Outlook to 2021
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 What Is This Report About? 5
2.2 Infectious Diagnostics Market Segmentation 5
2.3 Definitions of Markets Covered in the Report 6
3 Infectious Diagnostics Market, France 8
3.1 Infectious Diagnostics Market, France, Revenue ($m), 2007-2014 8
3.2 Infectious Diagnostics Market, France, Revenue ($m), 2014-2021 10
3.2.1 Infectious Diagnostics Rapid Tests and POC Market, France, Revenue ($m), by Segment, 2007-2014 12
3.2.2 Infectious Diagnostics Rapid Tests and POC Market, France, Revenue ($m), by Segment, 2014-2021 14
3.3 Infectious Diagnostics Market, France, Distribution Share by Revenue ($m), 2013-2014 16
3.4 Infectious Diagnostics Market, France, Company Share by Revenue ($m), 2014 17
4 Overview of Key Companies in France, Infectious Diagnostics Market 19
4.1 Abbott Laboratories 19
4.1.1 Company Overview 19
4.2 F. Hoffmann-La Roche Ltd. 19
4.2.1 Company Overview 19
4.3 Qiagen N.V. 19
4.3.1 Company Overview 19
4.4 Siemens Healthcare 20
4.4.1 Company Overview 20
4.5 bioMerieux S.A. 20
4.5.1 Company Overview 20
4.6 Bio-Rad Laboratories, Inc. 20
4.6.1 Company Overview 20
4.7 Alere Inc. 21
4.7.1 Company Overview 21
4.8 Danaher Corporation 21
4.8.1 Company Overview 21
5 Infectious Diagnostics Market Pipeline Products 22
6 Financial Deals Landscape 34
6.1 Partnerships 34
6.1.1 Biocartis Enters into Licensing and Development Agreement with Microbiome 34
6.1.2 BioMerieux Enters into Co-Development Agreement with Illumina 35
7 Recent Developments 36
7.1 Financial Announcements 36
7.1.1 Apr 23, 2015: bioMerieux - First-Quarter 2015 Business Review 36
7.1.2 Apr 23, 2015: bioMerieux - First-Quarter 2015 Business Review 39
7.1.3 Mar 11, 2015: bioMerieux - 2014 Financial Results 42
7.1.4 Dec 31, 2014: bioMerieux - Business Review for the Three Months and Full Year Ended December 31, 2014 44
7.1.5 Sep 03, 2014: bioMerieux First-Half 2014 Results 46
7.2 Legal And Regulatory 51
7.2.1 Jun 30, 2015: ImmunID Receives Accreditation From College of American Pathologists 51
7.3 Other Significant Developments 51
7.3.1 Jul 17, 2015: bioMerieux - First-Half 2015 Business Review 51
7.3.2 Mar 18, 2015: THERADIAG reinforces its RD and production capacities in new state-of-the-art facility 54
7.3.3 Sep 30, 2014: Biomerieux - Business Review for the Nine Months Ended September 30, 2014 55
7.4 Strategy And Business Planning 58
7.4.1 Oct 10, 2014: bioMerieux Inaugurates A New Multidisciplinary RandD Center For Infectious Disease Diagnostics 58
8 Appendix 61
8.1 Research Methodology 62
8.1.1 Coverage 62
8.1.2 Secondary Research 62
8.1.3 Primary Research 62
8.1.4 Company Share Analysis 63
8.1.5 Distribution Share Analysis 63
8.2 GlobalData Consulting 63
8.3 Contact Us 63
8.4 Disclaimer 64

1.1 List of Tables
Table 1: Infectious Diagnostics Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 9
Table 2: Infectious Diagnostics Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 11
Table 3: Infectious Diagnostics Rapid Tests and POC Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 13
Table 4: Infectious Diagnostics Rapid Tests and POC Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 15
Table 5: Infectious Diagnostics Market, France, Distribution Share by Revenue ($m), USD Constant, 2013-2014 16
Table 6: Infectious Diagnostics Market, France, Company Share by Revenue ($m), USD Constant, 2014 18
Table 7: Infectious Diagnostics Market Pipeline Products 22
Table 8: Biocartis Enters into Licensing and Development Agreement with Microbiome 34
Table 9: BioMerieux Enters into Co-Development Agreement with Illumina 35

1.2 List of Figures
Figure 1: Infectious Diagnostics Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 8
Figure 2: Infectious Diagnostics Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 10
Figure 3: Infectious Diagnostics Rapid Tests and POC Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 12
Figure 4: Infectious Diagnostics Rapid Tests and POC Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 14
Figure 5: Infectious Diagnostics Market, France, Company Share (%) 2014 17

Companies Mentioned
Abbott Laboratories
F. Hoffmann-La Roche Ltd.
Qiagen N.V.
Siemens Healthcare
bioMerieux S.A.
Bio-Rad Laboratories, Inc.
Alere Inc.
Danaher Corporation

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Europe Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

Europe Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 12800
  • Industry report
  • August 2016
  • by Venture Planning Group

This unique report provides information not available from any other published source, including volume, sales, and leading supplier shares by test. This comprehensive five-country report identifies and ...

Europe Cancer Diagnostics Market Future Horizons and Growth Strategies: Supplier Shares by Tumor Marker, Country Segment Forecasts, Competitive Intelligence, Opportunities

Europe Cancer Diagnostics Market Future Horizons and Growth Strategies: Supplier Shares by Tumor Marker, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 12800
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $19,700.  DataPack (test volumes, sales forecasts, supplier shares) $12,800.VPGMarketResearch.com's new report is a strategic analysis of the major business opportunities emerging in the ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.